Results for tag: "Injectable Cytotoxic Drugs"

Injectable cytotoxic drugs are a class of pharmaceuticals used primarily in the treatment of cancer. These drugs work by interfering with cell division, which is a characteristic of cancer cells, ultimately leading to cell death. In the context of healthcare services, these drugs are a critical component of chemotherapy protocols and are used across various settings, including hospitals, specialized cancer treatment centers, and outpatient clinics. The administration of such drugs requires a high level of care and precision, as they can be highly toxic not only to cancer cells but also to healthy cells. Therefore, healthcare professionals must closely monitor patients for side effects and adjust treatment plans accordingly. The market for these drugs includes both branded and generic medications, as well as a range of agents targeting different types of cancer. Several companies in the market that produce or supply injectable cytotoxic drugs include Pfizer, Roche, Eli Lilly and Company, Bristol-Myers Squibb, Novartis, Merck & Co., and Teva Pharmaceutical Industries. These companies are involved in the research, development, and distribution of these treatments, and they play a vital role in providing healthcare services with the necessary tools to manage and combat cancer. Show Less Read more